首页 | 本学科首页   官方微博 | 高级检索  
     

急性脑梗死静脉溶栓治疗的难点与对策
引用本文:方晓磊,刘金民,江涛. 急性脑梗死静脉溶栓治疗的难点与对策[J]. 中国康复理论与实践, 2007, 13(3): 222-224
作者姓名:方晓磊  刘金民  江涛
作者单位:北京中医药大学东方医院急诊科,北京市,100078
摘    要:本文指出按照国际指南以重组组织型纤溶酶原激活剂(r-tPA)进行规范静脉溶栓治疗急性脑梗死的重要性;提出了临床实践中常见的5方面问题:接受溶栓治疗的急性脑梗死患者较少、r-tPA的价格限制了临床应用、中国人r-tPA用量尚待摸索、溶栓疗效不理想以及中医药参与溶栓治疗有限,并对每一问题提出应对措施。对中医药干预超早期脑梗死溶栓治疗提出自己的想法。

关 键 词:急性脑梗死  经静脉溶栓  重组组织型纤溶酶原激活剂(r-tPA)  中医药
文章编号:1006-9771(2007)03-0222-03
收稿时间:2007-02-06
修稿时间:2007-02-06

Discussion for the Problems in Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction
FANG Xiao-lei,LIU Jin-min,JIANG Tao. Discussion for the Problems in Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction[J]. Chinese Journal of Rehabilitation Theory and Practice, 2007, 13(3): 222-224
Authors:FANG Xiao-lei  LIU Jin-min  JIANG Tao
Abstract:This paper points out the importance of intravenous thrombolysis with recombinant tissue plasminogen activator(r-tPA)according to the international guidelines in acute ischemic stroke.Some practical problems,such as the lower rate of thrombolysis for ischemic stroke,the price of r-tPA being too expensive to clinical using,the dosage of r-tPA in Chinese being not clear,the curative effect being not so good,and traditional Chinese medicine (TCM) applied in intravenous thrombolysis,and so on,should be further discussed.
Keywords:acute cerebral infarction  intravenous thrombolysis  recombinant tissue plasminogen activator (r-tPA)  traditional Chinese medicine (TCM)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号